|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | (2006.01) |
| C07K 14/705 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| C07K2319/30 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/04 | (2018.01) |
| (11) | Number of the document | 3241840 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17159334.6 |
| Date of filing the European patent application | 2011-01-21 | |
| (97) | Date of publication of the European application | 2017-11-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 336478 P | 2010-01-22 | US |
| (72) |
GIACCIA, Amato J. , US
RANKIN, Erinn Bruno , US
COCHRAN, Jennifer R. , US
JONES, Douglas , US
KARIOLIS, Mihalis , US
FUH, Katherine , US
MIAO, Yu , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY |
| INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY |